ANAB
$24.16
Anaptysbio
($.42)
(1.71%)
ANAB
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $1.94
Revenue:  $80.00 Mil
Wednesday
Feb 3
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ANAB reports earnings?
Beat
Meet
Miss

Where is ANAB's stock price going from here?
Up
Flat
Down
Stock chart of ANAB
Analysts
Summary of analysts' recommendations for ANAB
Score
Grade
Pivots
Resistance
$26.31
$25.85
$25.01

$24.55

Support
$23.71
$23.25
$22.41
Tweet
Growth
Description
AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.